Form 483

Lyne Laboratories, Inc. Form 483, 2011-03-25

FDA issued a Form 483 to Lyne Laboratories, Inc. on 2011-03-25 with 7 public-safe observations.

483· Form 483 issued7 observations

Lyne Laboratories, Inc. · Brockton, United States · Issued March 25, 2011

Overview

  • 7 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

25 Mar 2011
21 CFR 211.68(b)

Computer control of master formula records

Cited by Robert J Martin, Megan A Haggerty

25 Mar 2011
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Robert J Martin, Megan A Haggerty

25 Mar 2011
21 CFR 211.160(a)

Lab controls established, including changes

Cited by Robert J Martin, Megan A Haggerty

25 Mar 2011
21 CFR 211.182

Specific information required in individual logs

Cited by Robert J Martin, Megan A Haggerty

25 Mar 2011
21 CFR 211.186(b)(9)

Complete instructions, procedures, specifications et. al.

Cited by Robert J Martin, Megan A Haggerty

Inspected site

LLLyne Laboratories, Inc.Brockton, United States

Inspection team

MAMegan A Haggerty

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.182Cited across public-safe Form 483 observations1x
21 CFR 211.186(b)(9)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.194(b)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 7 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere